» Articles » PMID: 22717707

Enzymatic Transformation of the Major Ginsenoside Rb2 to Minor Compound Y and Compound K by a Ginsenoside-hydrolyzing β-glycosidase from Microbacterium Esteraromaticum

Overview
Specialty Biotechnology
Date 2012 Jun 22
PMID 22717707
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The ginsenoside-hydrolyzing β-glycosidase (Bgp3) derived from Microbacterium esteraromaticum transformed the major ginsenoside Rb2 to more pharmacologically active minor ginsenosides including compounds Y and K. The bgp3 gene consists of 2,271 bp encoding 756 amino acids which have homology to the glycosyl hydrolase family 3 protein domain. Bgp3 is capable of hydrolyzing beta-glucose links and arabinose links. HPLC analysis of the time course of ginsenoside Rb2 hydrolysis by Bgp3 (0.1 mg enzyme ml(-1) in 20 mM sodium phosphate buffer at 40 °C and pH 7.0) showed that the glycosidase first hydrolyzed the inner glucose moiety attached to the C-3 position and then the arabinopyranose moiety attached to the C-20 position. Thus, Bgp3 hydrolyzed the ginsenoside Rb2 via the following pathway: Rb2 → compound Y → compound K.

Citing Articles

Research progress on chemical diversity of saponins in .

Geng X, Wang J, Liu Y, Liu L, Liu X, Zhao Y Chin Herb Med. 2024; 16(4):529-547.

PMID: 39606259 PMC: 11589341. DOI: 10.1016/j.chmed.2024.08.005.


Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases.

Morshed M, Akter R, Karim M, Iqbal S, Kang S, Yang D Curr Issues Mol Biol. 2024; 46(3):2320-2342.

PMID: 38534764 PMC: 10968794. DOI: 10.3390/cimb46030148.


Kinetic conversion of BIOGF1K enriched in compound K from 3-D human tissue model.

Kim W, Choi W, Kim J, Choi J, Hong Y, Nam J Curr Res Pharmacol Drug Discov. 2023; 5:100165.

PMID: 37869704 PMC: 10589745. DOI: 10.1016/j.crphar.2023.100165.


Diversity and Isolation of Endophytic Fungi in and Biotransformation Activity on Saponins.

Li P, Ling X, Zhao S, Xu L, Wang R Curr Pharm Biotechnol. 2023; 25(9):1199-1208.

PMID: 37767797 DOI: 10.2174/0113892010247700230919053439.


Compound K Production: Achievements and Perspectives.

Chu L, Hanh N, Quyen M, Nguyen Q, Lien T, Van Do K Life (Basel). 2023; 13(7).

PMID: 37511939 PMC: 10381408. DOI: 10.3390/life13071565.


References
1.
Shin H, Park S, Sung J, Kim D . Purification and characterization of alpha-L-arabinopyranosidase and alpha-L-arabinofuranosidase from Bifidobacterium breve K-110, a human intestinal anaerobic bacterium metabolizing ginsenoside Rb2 and Rc. Appl Environ Microbiol. 2003; 69(12):7116-23. PMC: 309963. DOI: 10.1128/AEM.69.12.7116-7123.2003. View

2.
Wakabayashi C, Hasegawa H, Murata J, Saiki I . In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res. 1997; 9(8):411-7. View

3.
Christensen L . Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res. 2008; 55:1-99. DOI: 10.1016/S1043-4526(08)00401-4. View

4.
Mochizuki M, Yoo Y, Matsuzawa K, Sato K, Saiki I, Samukawa K . Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull. 1995; 18(9):1197-202. DOI: 10.1248/bpb.18.1197. View

5.
Song X, Zang L, Hu S . Amplified immune response by ginsenoside-based nanoparticles (ginsomes). Vaccine. 2009; 27(17):2306-11. DOI: 10.1016/j.vaccine.2009.02.040. View